Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 23;15(12):1653.
doi: 10.3390/genes15121653.

Epigenetic Regulation and Neurodevelopmental Disorders: From MeCP2 to the TCF20/PHF14 Complex

Gaea Dominguez  1 , Yongji Wu  1 , Jian Zhou  1   2
Affiliations
Review

Epigenetic Regulation and Neurodevelopmental Disorders: From MeCP2 to the TCF20/PHF14 Complex

Gaea Dominguez et al. Genes (Basel). .

Abstract

Background: Neurodevelopmental disorders (NDDs) affect approximately 15% of children and adolescents worldwide. This group of disorders is often polygenic with varying risk factors, with many associated genes converging on shared molecular pathways, including chromatin regulation and transcriptional control. Understanding how NDD-associated chromatin regulators and protein complexes orchestrate these regulatory pathways is crucial for elucidating NDD pathogenesis and developing targeted therapeutic strategies. Recently, the TCF20/PHF14 chromatin complex was identified in the mammalian brain, expanding the list of chromatin regulatory remodelers implicated in NDDs. This complex-which includes MeCP2, RAI1, TCF20, PHF14, and HMG20A-plays a vital role in epigenetic and transcriptional regulation.

Methods: We review and summarize current research and clinical reports pertaining to the different components of the MeCP2-interacting TCF20/PHF14 complex. We examine the NDDs associated with the TCF20/PHF14 complex, explore the molecular and neuronal functions of its components, and discuss emerging therapeutic strategies targeting this complex to mitigate symptoms, with broader applicability to other NDDs.

Results: Mutations in the genes encoding the components of the MeCP2-interacting TCF20/PHF14 complex have been linked to various NDDs, underscoring its critical contribution to brain development and NDD pathogenesis.

Conclusions: The MeCP2-interacting TCF20/PHF14 complex and its associated NDDs could serve as a model system to provide insight into the interplay between epigenetic regulation and NDD pathogenesis.

Keywords: HMG20A; MeCP2; PHF14; RAI1; Rett syndrome; TCF20; chromatin regulators; neurodevelopmental disorders; neuronal activity; transcription.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structural features of the MeCP2-interacting TCF20/PHF14 protein complex, its components, and the known interactions between them. The MeCP2-interacting TCF20/PHF14 protein complex (A) and their known interaction (B). This figure illustrates the interactions between the components of TCF20/PHF14 protein complex based on biochemical data. The complex is hypothesized to modulate shared downstream targets as depicted in (A). Blue arrows denote interactions where the domains between proteins have been mapped. Orange arrows pointing from protein domains to a protein name indicate that the interaction between the protein domains has not been fully established. N’: N-protein terminus; C’: C-protein terminus; IDR: intrinsically disordered domain; HMG: high-mobility group; CC: coiled-coil domain; MBD: methyl-CpG-binding domain; ID: intervening domain; TRD: transcriptional repression domain; PHD: plant homeodomain; TAD: transactivation domain; P1: PEST1 domain; DBD: DNA-binding domain; NBD: nucleosome-binding domain.
See this image and copyright information in PMC

References

    1. Gidziela A., Ahmadzadeh Y.I., Michelini G., Allegrini A.G., Agnew-Blais J., Lau L.Y., Duret M., Procopio F., Daly E., Ronald A., et al. A meta-analysis of genetic effects associated with neurodevelopmental disorders and co-occurring conditions. Nat. Hum. Behav. 2023;7:642–656. doi: 10.1038/s41562-023-01530-y. - DOI - PMC - PubMed
    1. Indelicato E., Zech M., Amprosi M., Boesch S. Untangling neurodevelopmental disorders in the adulthood: A movement disorder is the clue. Orphanet J. Rare Dis. 2022;17:55. doi: 10.1186/s13023-022-02218-8. - DOI - PMC - PubMed
    1. Moffitt T.E., Houts R., Asherson P., Belsky D.W., Corcoran D.L., Hammerle M., Harrington H., Hogan S., Meier M.H., Polanczyk G.V., et al. Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence from a Four-Decade Longitudinal Cohort Study. Am. J. Psychiatry. 2015;172:967–977. doi: 10.1176/appi.ajp.2015.14101266. - DOI - PMC - PubMed
    1. Liah M., Andrew L., Mark M., Tim F., Eavan M., Lisa C. Adult onset neurodevelopmental disorder with regression, abnormal movement, loss of speech and seizures (NEDAMSS); Proceedings of the Association of British Neurologists: Annual Meeting Abstracts; Belfast, UK. 20 May 2023; p. A79.
    1. McRae J.F., Clayton S., Fitzgerald T.W., Kaplanis J., Prigmore E., Rajan D., Sifrim A., Aitken S., Akawi N., Alvi M., et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433–438. - PMC - PubMed

MeSH terms

LinkOut - more resources